NeoOVSV vaccine for ovarian cancer after surgery
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests a personalized vaccine made from your own tumor tissue called NeoOVSV. It is meant to train your immune system to fight any remaining cancer after surgery. The vaccine is a personal treatment because it uses your tumor's unique markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 75 years.
- You have been surgically treated for a certain type of ovarian cancer (epithelial) and your surgery achieved clear margins under a microscope.
- Your MRI or CT scan after surgery shows no visible cancer remaining.
- You are generally in good health without severe heart, liver, kidney, or other serious illnesses.
- You have not received a cancer vaccine, immunotherapy (like PD-1 inhibitors), or certain other drugs within a set time before the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine made from your tumor's genetic material. It is given after surgery to help your immune system recognize and attack any remaining cancer cells, with the goal of preventing the cancer from coming back.
This trial tests a personalized cancer vaccine made from your own tumor cells. It is for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has returned after at least one round of platinum chemotherapy.
This trial tests a vaccine called CryptiVax-1001 for people with advanced ovarian cancer who have finished first-line chemotherapy and are in remission, as maintenance therapy. The goal is to see if the vaccine can help keep the cancer from coming back.
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) that are trained to recognize specific markers on your ovarian cancer. The goal is to see if this vaccine is safe and helps your immune system fight the cancer.
This trial tests a personalized vaccine for people with epithelial ovarian cancer who still have a small amount of cancer DNA in their blood after surgery. The goal is to see if the vaccine can help stop the cancer from coming back.
This trial studies a vaccine made from your immune cells (dendritic cell vaccine) given before chemotherapy and surgery. It aims to help your body recognize and fight ovarian cancer more effectively in people whose cancer is advanced and spread.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.